 |
|
|
| |
Glecaprevir/Pibrentasvir is Effective and Well Tolerated in Hepatitis C Patients With Cirrhosis: Real-World Experience From the German Hepatitis C-Registry
|
| |
| |
AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
Heiner Wedemeyer1,2, Peter Erren3, Uwe Naumann4, Ansgar Rieke5, Albrecht Stoehr6, Tim Zimmermann7, Kristina Lohmann8, Bettina König8, Stefan Mauss91Department of Gastroenterology and Hepatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; 2Leberstiftungs-GmbH Deutschland, Germany; 3MVZ Portal 10, Munster, Germany; 4UBN/Praxis, Berlin, Germany; 5Gemeinschaftsklinikum Mittelrhein, Kemperhof, Koblenz, Germany; 6ifi-Institut fur interdisziplinare Medizin, Hamburg, Germany; 7Universitatsklinikum Mainz, Mainz, Germany; 8AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany; 9Center for HIV and Hepatogastroenterology, Dusseldorf, Germany
|
| |
|
|
|
|
|
